Tuesday 14 Jul, 2020 09:30 PM
Site map | Locate Us | Login
   Wipro Q1 PAT rises 2.7% QoQ to Rs 2390 cr     Eveready Inds spurts after Burman family ups stake    Mindtree Q1 PAT rises 3.3% QoQ    SKF India Ltd leads losers in 'A' group    Zodiac-JRD-MKJ Ltd leads losers in 'B' group    Volumes jump at GE T&D India Ltd counter    Metal shares fall    Financials shares slide    Banking shares ease    Dr. Reddy's Labs gains on launching Nicotine lozenges in US    Motherson Sumi slips after Moody's lowers outlook to negative    Century Textiles skids on dismal Q1 performance    Hathway Cable & Datacom Ltd up for third consecutive session    Biocon Ltd spurts 3.83%, gains for five straight sessions    Auto stocks tumble as sales dip in June 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
Lupin gains after Nagpur facility receives EIR
18-Oct-19   14:52 Hrs IST

Lupin announced the receipt of the establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for its Nagpur facility. The facility was inspected by the USFDA between 5 and 8 August 2019. The inspection for the oral solid facility at Nagpur closed without any Form 483 observation.

The Nagpur facility is Lupin's largest and most advanced oral solid dosage facility and has maintained a solid track record of compliance.

Commenting on the receipt of the EIR, Nilesh Gupta, managing director, Lupin said, Excelling at quality and compliance is one of our top priorities and we remain committed to meeting and exceeding standards set by regulatory agencies globally.

Meanwhile, the S&P BSE Sensex was up 646 points or 1.72% to 38,177.95. The Nifty Pharma Index was trading 1.03% higher at 7,611.40.

On the BSE, 44,098 shares were traded in the counter so far compared with average daily volumes of 64,929 shares in the past two weeks. The stock hit a high of Rs 746 and a low of Rs 723.05 so far during the day.

The stock hit a 52-week high of Rs 914 on 31 October 2018 and a 52-week low of Rs 646.2 on 7 October 2019.

Lupin's consolidated net profit jumped 49.5% to Rs 303.05 crore on a 15.4% surge in net sales to Rs 4,355.83 crore in Q1 June 2019 compared with Q1 June 2018.

Lupin is engaged in producing, developing and marketing a range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) across the world.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.G Anand , anand@ssplwealth.com
Hit Count : 14410619
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016  |  MCX : INZ000081736
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 12815 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. Saravana Stocks Pvt. Ltd